Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

Summary by TechCrunch
The de-extinction startup is looking to double or triple its previous valuation, according to the report.

2 Articles

TechCrunchTechCrunch
Reposted by
blkalerts.comblkalerts.com
Center

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

The de-extinction startup is looking to double or triple its previous valuation, according to the report.

·San Francisco, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

TechCrunch broke the news in San Francisco, United States on Monday, July 20, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Startups icon

Startups

Austin, Texas icon

Austin, Texas

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal